BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35459888)

  • 21. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor.
    Meier-Abt F; Kraemer D; Braun N; Reinehr M; Stutz-Grunder E; Steindl K; Rauch A
    Am J Med Genet A; 2024 Jun; 194(6):e63528. PubMed ID: 38169111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.
    Yeh A; Wei M; Golub SB; Yamashiro DJ; Murty VV; Tycko B
    Genes Chromosomes Cancer; 2002 Oct; 35(2):156-63. PubMed ID: 12203779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
    Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
    Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc finger point mutations within the WT1 gene in Wilms tumor patients.
    Little MH; Prosser J; Condie A; Smith PJ; Van Heyningen V; Hastie ND
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4791-5. PubMed ID: 1317572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus.
    Ton CC; Huff V; Call KM; Cohn S; Strong LC; Housman DE; Saunders GF
    Genomics; 1991 May; 10(1):293-7. PubMed ID: 1646159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
    Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
    Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
    [No Abstract]   [Full Text] [Related]  

  • 28.
    Moore C; Monforte H; Teer JK; Zhang Y; Yoder S; Brohl AS; Reed DR
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32699065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13.
    Francke U; Holmes LB; Atkins L; Riccardi VM
    Cytogenet Cell Genet; 1979; 24(3):185-92. PubMed ID: 225131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
    Reeve AE; Sih SA; Raizis AM; Feinberg AP
    Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilms tumour: a developmental anomaly.
    Hastie ND; Bickmore W; Pritchard-Jones K; Porteous DJ; van Heyningen V
    Princess Takamatsu Symp; 1989; 20():145-50. PubMed ID: 2562179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
    Maiti S; Alam R; Amos CI; Huff V
    Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Wilms' tumors and malformation complexes].
    Hata J; Fukuzawa R; Takata A; Kikuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
    Nordenskjöld A; Friedman E; Anvret M
    Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent hypermethylation of a CTCF binding site influences Wilms tumor 1 expression in Wilms tumors.
    Zitzmann F; Mayr D; Berger M; Stehr M; von Schweinitz D; Kappler R; Hubertus J
    Oncol Rep; 2014 Apr; 31(4):1871-6. PubMed ID: 24534946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Del 11p/aniridia complex. Report of three patients and review of 37 observations from the literature.
    Turleau C; de Grouchy J; Tournade MF; Gagnadoux MF; Junien C
    Clin Genet; 1984 Oct; 26(4):356-62. PubMed ID: 6094051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms' tumor, malformative syndrome, mental retardation and de novo constitutional translocation, t(7;13)(q36;q13).
    Bernard JL; Baeteman MA; Mattei JF; Raybaud C; Giraud F
    Eur J Pediatr; 1984 Jan; 141(3):175-7. PubMed ID: 6321191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms' tumour: reconciling genetics and biology.
    Van Heyningen V; Hastie ND
    Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aniridia, gonadoblastoma, Wilms' tumor and deletion 11p13.
    Stefan H; Semecký V
    Acta Medica (Hradec Kralove); 1998; 41(1):29-33. PubMed ID: 9588071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.